Diltiazem Hydrochloride Capsule, Extended Release
Pricing Report NDC 68682-367-90

Latest NADAC: $0.21604 per EA · Effective Sep 17, 2025 · Est. package price $19.44 (90 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Diltiazem Hydrochloride Extended Release (NDC 68682-367-90) is $0.21604 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a a human prescription drug provided by Oceanside Pharmaceuticals, this medication is distributed in a 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.21604
Per EA

Effective Date
Sep 17, 2025
Billable Units
90 EA
Estimated Package Price
$19.44
Data Status
As of Oct 01, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.16879 to $0.53383 per EA. Over this 10 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1688 - $0.5338
Market Volatility
216.27% Variance
Latest Trend
1.50%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 17, 2025 $0.21604 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $0.21284 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $0.23195 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $0.23534 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $0.24623 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $0.23783 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $0.23474 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $0.22314 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $0.20288 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $0.19665 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $0.16879 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $0.20744 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026